- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05395403
Use of Automated Office Blood Pressure Monitoring
May 24, 2022 updated by: Tonya Breaux-Shropshire, University of Alabama at Birmingham
Use of Automated Office Blood Pressure Monitoring in Older Working-age Adults
Blood pressure measurements by three methods Office Blood Pressure Measurement (OBPM), Automated Office Blood Pressure Measurement (AOBPM), and Home Blood Pressure Measurement (HBPM) were collected retrospectively across three visits for patients (N=28) referred to a specialty hypertension (HTN) clinic.
Demographic data were analyzed using summary statistics.
The differences between AOBPM, HBPM, and OBPM were examined using mixed models repeated measures analysis for time and method for each visit.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 19 years and older
- Uncontrolled BP
- Prescribed three or more antihypertensive medications at the time of referral
- Higher risk for poor CV outcomes than patients with essential HTN
- OBPM systolic BP of greater than 140 mmHg and diastolic BP of greater than or equal to 90 mm Hg upon initial clinic assessment.
Exclusion Criteria:
- Less than 19 years old
- Had a systolic BP of less than 140 mm Hg and diastolic BP of less than 90 mmHg upon initial clinic assessment.
- Also, patients on less than three antihypertensive medications, with less than three visits, and who have controlled OBPM were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SCREENING
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Office Blood Pressure Measurement (OBPM)
Traditional office blood pressure monitoring in the primary care clinical environment.
|
The use of three different devices: traditional office blood pressure measurement cuff (OBPM), automated office blood pressure measurement cuff (AOBPM), and home blood pressure measurement cuff (HBPM).
|
EXPERIMENTAL: Automated Office Blood Pressure Measurement (AOBPM)
Blood pressure measurement using a validated BpTRU device
|
The use of three different devices: traditional office blood pressure measurement cuff (OBPM), automated office blood pressure measurement cuff (AOBPM), and home blood pressure measurement cuff (HBPM).
|
EXPERIMENTAL: Home Blood Pressure Measurement (HBPM)
Blood pressure measurement at patient's home using home monitoring device.
|
The use of three different devices: traditional office blood pressure measurement cuff (OBPM), automated office blood pressure measurement cuff (AOBPM), and home blood pressure measurement cuff (HBPM).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants using Traditional office blood pressure measurement (OBPM)
Time Frame: Baseline
|
Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg
|
Baseline
|
Number of participants using Traditional office blood pressure measurement (OBPM)
Time Frame: Up to 8 weeks
|
Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg
|
Up to 8 weeks
|
Number of participants using Traditional office blood pressure measurement (OBPM)
Time Frame: Up to 16 weeks
|
Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg
|
Up to 16 weeks
|
Number of participants using Automated office blood pressure measurement (AOBPM)
Time Frame: Baseline
|
Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg
|
Baseline
|
Number of participants using Automated office blood pressure measurement (AOBPM)
Time Frame: Up to 8 weeks
|
Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg
|
Up to 8 weeks
|
Number of participants using Automated office blood pressure measurement (AOBPM)
Time Frame: Up to 16 weeks
|
Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg
|
Up to 16 weeks
|
Number of participants using Home blood pressure measurement (HBPM)
Time Frame: Baseline
|
Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg
|
Baseline
|
Number of participants using Home blood pressure measurement (HBPM)
Time Frame: Up to 8 weeks
|
Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg
|
Up to 8 weeks
|
Number of participants using Home blood pressure measurement (HBPM)
Time Frame: Up to 16 weeks
|
Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg
|
Up to 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 5, 2021
Primary Completion (ACTUAL)
July 5, 2021
Study Completion (ACTUAL)
July 5, 2021
Study Registration Dates
First Submitted
April 19, 2022
First Submitted That Met QC Criteria
May 24, 2022
First Posted (ACTUAL)
May 27, 2022
Study Record Updates
Last Update Posted (ACTUAL)
May 27, 2022
Last Update Submitted That Met QC Criteria
May 24, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300006396
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
Clinical Trials on Blood pressure measurement device
-
Leo WangBTS InternationalCompletedHypertension | Efficacy of Wrist BPM MeasurementChina
-
Kaiser PermanentePatient-Centered Outcomes Research InstituteCompleted
-
BTS InternationalClinimark, LLC; Guangdong Transtek Medical Electronics Co., Ltd.CompletedBlood PressureUnited States
-
Renaissance University Ugbawka, EnuguEnrolling by invitation
-
Summit Doppler Systems, Inc.The Cleveland ClinicCompletedPeripheral Arterial DiseaseUnited States
-
Hospital Clinic of BarcelonaRecruitingArterial Hypertension | Frailty Syndrome | Heart Failure With Preserved Ejection Fraction | Comorbidities and Coexisting ConditionsSpain
-
University Hospital OlomoucCompleted
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Albany Medical CollegeCompleted